Ethoderm

Henderson, United States Founded: 2022 • Age: 4 yrs
Transdermal drug delivery technology for chronic diseases is developed.

About Ethoderm

Ethoderm is a Healthcare company based in Henderson (United States) founded in 2022. Transdermal drug delivery technology for chronic diseases is developed. Ethoderm offers products and services including Transdermal Delivery Technology. Its focus areas include Life Sciences, Drug Delivery and Topical. Its legal entity is Ethoderm Inc. Its competitors include PanTher Therapeutics, Zyl Therapeutics and Hallux; 3 of its 3 listed competitors have raised funding.

Company details

Ethoderm was founded in 2022 and is based in Henderson, United States. Operations are focused on the biotechnology sector, where transdermal drug delivery systems are developed to address chronic diseases. Research and innovation efforts are directed toward improving drug administration methods through skin-based technologies. The companys domain is etoderm.com, supporting its activities in pharmaceutical advancements for long-term health conditions.

  • Headquarters Henderson, United States
  • Sectors
    Healthcare
  • Website ethoderm.com
  • Social LinkedIn X
  • Legal Name Ethoderm Inc.

Products & Services of Ethoderm

Ethoderm offers a comprehensive portfolio of products and services, including Transdermal Delivery Technology.

Transdermal Delivery Technology
Drug Delivery Platform

Platform for topical gel-based delivery of therapeutics to treat chronic diseases effectively.

People of Ethoderm

10 people are tracked at Ethoderm (2 in leadership, 8 in board & advisors).

NameRoleGroup
Max Pringle
COOLeadership
Kiira M. Lizza
Director Of Sales And Marketing, VelocityLeadership
Timothy Sharpe
Scientific AdvisorBoard & advisors
JD Peters
AdvisorBoard & advisors
Manjit Gosal
Scientific AdvisorBoard & advisors
Eric Fehr
DirectorBoard & advisors
Andreas Popper
DirectorBoard & advisors
Shawn Henry
AdvisorBoard & advisors
Reginald B. O'Hara
AdvisorBoard & advisors
Dan Pardi
Scientific AdvisorBoard & advisors
Premium access

Complete people profiles for Ethoderm

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Ethoderm

Ethoderm has 3 listed competitors in our database, 3 of them funded. They include PanTher Therapeutics, Zyl Therapeutics and Hallux.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
panthertx.com2014Cambridge, United States$15.35M47
Drug delivery systems for inoperable solid tumors are developed.
zylotherapeutics.com2017Greenville, United States$9.43M
Hydrogel-derived nanoparticles for topical drug delivery are developed.
halluxinc.com2012Laguna Hills, United States$27.2M
Subungual drug delivery technology for onychomycosis treatment is provided.
Premium access

Detailed competitors of Ethoderm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Ethoderm (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ethoderm

Ethoderm was founded in 2022.

Ethoderm is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.

Ethoderm was founded in 2022 and is based in Henderson, United States. Operations are focused on the biotechnology sector, where transdermal drug delivery systems are developed to address chronic diseases. Research and innovation efforts are directed toward improving drug administration methods through skin-based technologies. The companys domain is etoderm.com, supporting its activities in pharmaceutical advancements for long-term health conditions.

Ethoderm's top competitors include PanTher Therapeutics, Zyl Therapeutics and Hallux.

Ethoderm offers Transdermal Delivery Technology.

Ethoderm operates through Ethoderm Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available